Cargando…

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors

SIMPLE SUMMARY: We demonstrate that, in pediatric embryonal brain tumors, cell-free DNA extracted from CSF can be used for whole exome sequencing (WES), with informative results in 83% of samples. Importantly, in comparison to the WES of primary tumor tissue, clonal heterogeneity is identified in mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chicard, Mathieu, Iddir, Yasmine, Masliah Planchon, Julien, Combaret, Valérie, Attignon, Valéry, Saint-Charles, Alexandra, Frappaz, Didier, Faure-Conter, Cécile, Beccaria, Kévin, Varlet, Pascale, Geoerger, Birgit, Baulande, Sylvain, Pierron, Gaelle, Bouchoucha, Yassine, Doz, François, Delattre, Olivier, Waterfall, Joshua J., Bourdeaut, Franck, Schleiermacher, Gudrun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340330/ https://www.ncbi.nlm.nih.gov/pubmed/37444642 http://dx.doi.org/10.3390/cancers15133532

Ejemplares similares

Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR ‐rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

ETMR-03. Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family
por: Bouchoucha, Yassine, et al.
Publicado: (2022)

A malignant choroid plexus tumour with prevailing immature blastematous elements
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

MBRS-37. RECURRENT ACTIVATING MUTATIONS OF AKT GENES IN WNT-ACTIVATED MEDULLOBLASTOMAS
por: Masliah-Planchon, Julien, et al.
Publicado: (2020)

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
por: Bellini, Angela, et al.
Publicado: (2019)

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

MBRS-47. RAPID MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA BASED ON DNA METHYLATION BY NANOPORE SEQUENCING
por: Masliah-Planchon, Julien, et al.
Publicado: (2020)

Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2017)

Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

MEDB-84. The French experience of ELP1-related medulloblastomas
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
por: Berlanga, Pablo, et al.
Publicado: (2022)

ATRT-11. Anatomico-biological correlations define a new layer for ATRT molecular subgroups pointing to potential lineages of origin
por: Lobon-Iglesias, Maria, et al.
Publicado: (2022)

ATRT-21. Contribution of germline mosaic alterations of SMARCB1 in rhabdoid tumor predisposition syndrome
por: Masliah-Planchon, Julien, et al.
Publicado: (2022)

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2020)

CNS tumors with YWHAE:NUTM2 and KDM2B-fusions present molecular similarities to extra-CNS tumors having BCOR internal tandem duplication or alternative fusions
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups
por: Lobón-Iglesias, María-Jesús, et al.
Publicado: (2023)

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
por: Han, Zhi-Yan, et al.
Publicado: (2016)

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations
por: Durand, Simon, et al.
Publicado: (2019)

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression
por: Petrirena, Gregorio J., et al.
Publicado: (2018)

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction
por: Deveau, Paul, et al.
Publicado: (2018)

Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse
por: de Traux de Wardin, Henry, et al.
Publicado: (2023)

Detection of tumor ALK status in neuroblastoma patients using peripheral blood
por: Combaret, Valérie, et al.
Publicado: (2015)

ATRT-27. COST-EFFECTIVE ASSAYS TO SUBGROUP ATRT IN THE DAILY ROUTINE
por: Lobon-Iglesias, María-Jesús, et al.
Publicado: (2020)

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
por: Euskirchen, Philipp, et al.
Publicado: (2017)

SegAnnDB: interactive Web-based genomic segmentation
por: Hocking, Toby D., et al.
Publicado: (2014)

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis
por: Boeva, Valentina, et al.
Publicado: (2013)

An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
por: Morabito, Morgane, et al.
Publicado: (2019)

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study
por: Ruhen, Olivia, et al.
Publicado: (2022)

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
por: Richer, Wilfrid, et al.
Publicado: (2017)

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
por: Costa, Ana, et al.
Publicado: (2022)

Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN
por: Guimier, Anne, et al.
Publicado: (2014)

MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA
por: Dufour, Christelle, et al.
Publicado: (2020)

Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia
por: Siegfried, Aurore, et al.
Publicado: (2019)

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
por: Lak, Nathalie S.M., et al.
Publicado: (2023)

High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations
por: Forest, Fabien, et al.
Publicado: (2022)

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
por: Thirant, Cécile, et al.
Publicado: (2023)

Central nervous system germ cell tumor, an archetypal AYA tumor and a model for pediatric and neuro-oncology collaboration, review from the EURACAN domain 10 group
por: Faure Conter, Cecile, et al.
Publicado: (2022)

Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours
por: Métais, Alice, et al.
Publicado: (2022)

Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
por: Brisse, Hervé J., et al.
Publicado: (2017)

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
por: Masliah-Planchon, Julien, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0dlecp300nnu4e41gin2nn2kpi